Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

about

Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

P2860

Q33754912-9EBFC5CD-F6BD-49F3-A6E9-FD9533CECDA6 Q54656425-E0E0D024-A778-4FDC-A6B7-AF74F017EA70

P2860

Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

Item

http://www.wikidata.org/entity/Q43519814

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@en

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@nl

type

Item

label

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@en

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@nl

prefLabel

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@en

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@nl

P1476

Inhibition of CYP3A4 and CYP2C ...... inical drug-drug interactions.

@en

P2093

Bin Chen

http://www.w3.org/2001/XMLSchema#string

Dai-Hong Ji

http://www.w3.org/2001/XMLSchema#string

Dong-Xue Sun

http://www.w3.org/2001/XMLSchema#string

Feng-De Tian

http://www.w3.org/2001/XMLSchema#string

Jie Pu

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Jin-Hui Song

http://www.w3.org/2001/XMLSchema#string

Lin Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes

Etoposide: four decades of development of a topoisomerase II inhibitor

Predicting in vivo drug interactions from in vitro drug discovery data.

Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation.

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

In vitro approaches to investigate mechanism-based inactivation of CYP enzymes.

Current status of etoposide in the management of small cell lung cancer.

The clinical pharmacology of etoposide.

Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes.

Enzyme-assisted asymmetric total synthesis of (-)-podophyllotoxin and (-)-picropodophyllin.

P2888

s12038-011-9143-9

P304

879-885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12038-011-9143-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51829602

http://www.w3.org/2001/XMLSchema#string

P6179

1001739147

http://www.w3.org/2001/XMLSchema#string

P698

22116286

http://www.w3.org/2001/XMLSchema#string

Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

about

P2860

P2860

Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698